Rest and stress myocardial perfusion imaging, described nearly 4 decades ago (1) , is now performed in Ͼ9 million people annually in the United States (2) . The procedure provides clinically useful data regardless of whether the tracer is a monovalent cation such as potassium, thallium, or rubidium; a highly diffusible agent such as 15 O-labeled water; an amino acid precursor such as ammonia; or a lipophilic agent such as sestamibi or tetrofosmin. All of the radiopharmaceuticals proposed to measure myocardial perfusion, regardless of their chemical composition, mechanism of uptake, or mechanism of myocardial retention, follow the Sapirstein principle.
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In 1956, Sapirstein (3) described the behavior of potassium-42 as an indicator to measure the distribution of cardiac output:
"A foreign substance, after a single intravenous administration, will be distributed initially to the organs in proportion to their blood flow. The substance will then be carried away from the organs by their venous drainage. For a certain period of time, however, the venous drainage will be negligibly small compared to the arterial delivery. During this time the fractional distribution of the substance among the organs will correspond to the fractional distribution of the cardiac output among them."
Sapirstein indicated that a perfect indicator of perfusion required an extraction fraction of 1 by the organ. Subsequent investigators demonstrated that agents that are significantly retained by the organ, even with an extraction Ͻ1, still provide accurate measurements of regional and absolute perfusion (4 -6) and perfusion reserve (7, 8) , if imaging is performed before significant loss of indicator from the tissue. Delayed imaging does not necessarily reflect perfusion at the time of injection due to different rates of tracer clearance from normal and ischemic territories (9, 10) . For example, once in the cell, monovalent cations, such as thallium, potassium, and rubidium, reside in the cytoplasm, mixing with the intracellular potassium pool. These agents are lost from the cell in proportion to their intracellular concentration (greater loss from areas with higher concentration). On the other hand, the relative loss of tetrofosmin (11) and sestamibi (12) is substantially slower than the monovalent cations (Table 1 ). Both technetium tracers are highly lipophilic, with a ϩ1 charge distributed over the surface of the molecule. These agents are retained by binding to mitochondria. This mechanism of retention does not alter the value of these agents as indicators of perfusion. The potential additional information related to retention may be useful to evaluate other diseases of the myocardium (see the following section).
Fast-forward to the second decade of the 21st century. Hybrid positron imaging devices such as positron emission tomography (PET) and computed tomography (CT), provide high-resolution, readily quantified images. PET-CT myocardial perfusion imaging offers data of higher diagnostic quality than single-photon emission computed tomography, allowing greater certainty of interpretation (13). Regional and global myocardial perfusion reserve can be readily calculated from PET perfusion data, providing additional information to evaluate flow-limiting arterial disease (14, 15) . The short half-life of the most frequently used PET perfusion agent, rubidium-82, has made pharmacologic stress the standard (16) . Despite higher quality quantitative images, PET perfusion studies do not provide information about a patient's work capacity. Exercise stress testing provides this prognostic information. Developing a positron-emitting radiopharmaceutical with a long enough half-life to permit exercise stress testing would address this problem. Preliminary data with the fluorine-18 labeled perfusion agent flurpiridaz, now in clinical trials, suggest that it is useful for both detection of regional myocardial perfusion abnormalities and calculation of myocardial flow reserve (17, 18) . Flurpiridaz is derived from the pharmacophore pyridaben (used as an insecticide) (19) . The radiolabeled complex binds to mitochondria by interacting with mitochondrial complex 1.
In this issue of iJACC, Gurm et al. (20) (24) by calculating mitochondrial transmembrane potential in the hearts of these animals with severe myocardial ischemia.
Ischemia was induced by partial inflation of an angioplasty balloon in the mid left anterior descending coronary artery (sufficient obstruction of flow to produce 1-to 2-mm ST-segment elevation in the anterior precordial leads). Rhythm was stabilized with amiodarone and lidocaine, and blood pressure was stabilized with phenylephrine infusion. Once stabilized, adenosine was infused intravenously and continued for the duration of the experiment. Phenylephrine infusion was adjusted as necessary to maintain arterial pressure. After a second injection of microspheres, F-Phe-TPP was administered intravenously and serial PET images were recorded, and at the conclusion of the study, samples were counted.
The investigators observed an excellent correlation between the distribution of relative perfusion as measured by microspheres and relative distribution of F-Phe-TPP (Fig. 3A in Gurm et al. [20] ). Unfortunately, there was no correlation with absolute perfusion (Fig. 3B in Gurm et al. [20] ). The reason for this lack of correlation is unclear. It is unlikely that this is due to a "roll-off" of extraction because the data in Figure 5 (20) show that K1 (K1 ϭ myocardial blood flow ϫ extraction fraction) is relatively constant, even at flows Ͼ3 ml/min/g. The stability of myocardial uptake shown by Shoup et al. (24) and Gurm et al. (20) is important, because the concentration of 18 F-TPP in the lungs decreases from 0.69% of the injected dose (ID)/g at 5 min to 0.36%ID/g at 30 min and in the liver from 0.34%ID/g at 5 min to 0.18%ID/g at 30 min. Thus, a brief delay between tracer injection and imaging should enhance the heart-to-background ratio, im- proving detection of subtle regions of decreased perfusion, but without concern about differential myocardial tracer loss from redistribution. Table 1 summarizes myocardial retention of several perfusion tracers at 5 and 60 min after injection. In addition to the lack of correlation with absolute flow, it is unclear why the calculated extraction fraction of 18 F-TPP is so low (ϳ0.26), and why extraction did not decrease with adenosine infusion. However, the uptake of F-Phe-TPP in normal zones and in areas of ischemia is stable, as depicted in Figures 6A and 6B in the Gurm et al. (20) study.
Clinical Implications
F-Phe-TPP rapidly localizes in the myocardium and is retained without significant redistribution over intervals of ϳ30 min. Regional tracer distribution mirrors relative myocardial perfusion. These characteristics suggest that this agent will be useful for myocardial perfusion imaging. Additional studies are needed to evaluate the low extraction fraction and clarify the lack of correlation of F-Phe-TPP uptake and absolute flow.
Myocardial retention that reflects mitochondrial transmembrane potential may add information beyond that available from the measurement of perfusion alone. As cells undergo apoptosis, for example, mitochondrial transmembrane potential decreases, reducing retention of tracers that localize in mitochondria (27) . On the other hand, when myocardium becomes ischemic, mitochondria become hyperpolarized (28) . These changes should be reflected by changes in tracer retention.
In heart failure, for example, there is a significant deficiency of mitochondrial adenosine triphosphate production (29) . Because sestamibi localizes in the myocardium in proportion to the cell membrane and mitochondrial transmembrane potential (30, 31) , retention of the tracer in the heart may be altered by heart failure. This concept was investigated by Takehana et al. (32) . These investigators demonstrated an inverse relationship between the rate of sestamibi clearance and left ventricular ejection fraction in patients with dilated cardiomyopathy. It is likely that similar observations will be made for F-Phe-TPP.
Based on the quality of the images and the stability of myocardial uptake in the initial 30 min of imaging, F-Phe-TPP deserves further evaluation as an agent for imaging the myocardium. 
